Here’s the fact that surprises most people: Ozempic and Wegovy are the same medication (semaglutide), just sold under different brand names, at different doses, for different approved uses. Ozempic is approved for type 2 diabetes; Wegovy is approved for weight management. So if your goal is weight loss, Wegovy is the on-label version, though the underlying drug is identical. Here’s what actually separates them and why two brands exist.<\/p>\n
It comes down to how drugs get approved. Novo Nordisk developed semaglutide and first brought it to market as Ozempic for type 2 diabetes. When trials showed it also produced substantial weight loss, the company sought a separate approval for obesity and branded that version Wegovy, at a higher maximum dose. Same molecule, two brands, two sets of approved uses. This is why you’ll hear the drugs discussed almost interchangeably, even though they’re marketed differently.<\/p>\n
| Feature<\/th>\n | Ozempic<\/th>\n | Wegovy<\/th>\n<\/tr>\n<\/thead>\n |
|---|---|---|
| Active drug<\/td>\n | Semaglutide<\/td>\n | Semaglutide<\/td>\n<\/tr>\n |
| Approved for<\/td>\n | Type 2 diabetes<\/td>\n | Weight management<\/td>\n<\/tr>\n |
| Max dose<\/td>\n | 2 mg<\/td>\n | 2.4 mg (plus a 7.2 mg high dose)<\/td>\n<\/tr>\n |
| Also approved for<\/td>\n | Cardiovascular risk (in diabetes)<\/td>\n | Cardiovascular risk, MASH, and a pill form<\/td>\n<\/tr>\n |
| Form<\/td>\n | Weekly injection<\/td>\n | Weekly injection (and now an oral tablet)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\nThe Dose Difference<\/h3>\nThe doses differ slightly. Ozempic goes up to 2 mg weekly, while Wegovy goes up to 2.4 mg (with an even higher 7.2 mg option added recently). Since weight loss is dose-dependent, the weight-management version is dosed to maximize that effect. In practice, at comparable doses the weight loss is similar, because it’s the same drug, but Wegovy is specifically titrated and approved for obesity. Consider a hypothetical patient who hears friends rave about “Ozempic for weight loss”: they’re really describing semaglutide’s effect, which Wegovy delivers as the approved weight-management product.<\/p>\n Approved Uses Are Diverging<\/h3>\n |